Cargando…

Marked Hyperbilirubinemia Associated with Primary Myelofibrosis Responsive to Ruxolitinib

Primary myelofibrosis (PMF) is a chronic myeloproliferative disorder seen in older adults which can present both with hepatosplenomegaly as well as mild nonspecific liver enzyme abnormalities. Mild elevations in bilirubin can occasionally be seen due to both intravascular hemolysis as well as extram...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandhu, Sunny, Chaudhry, Hunza, Zhang, Sharon, Prajapati, Devang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167125/
https://www.ncbi.nlm.nih.gov/pubmed/35669160
http://dx.doi.org/10.1155/2022/9630996
_version_ 1784720762597277696
author Sandhu, Sunny
Chaudhry, Hunza
Zhang, Sharon
Prajapati, Devang
author_facet Sandhu, Sunny
Chaudhry, Hunza
Zhang, Sharon
Prajapati, Devang
author_sort Sandhu, Sunny
collection PubMed
description Primary myelofibrosis (PMF) is a chronic myeloproliferative disorder seen in older adults which can present both with hepatosplenomegaly as well as mild nonspecific liver enzyme abnormalities. Mild elevations in bilirubin can occasionally be seen due to both intravascular hemolysis as well as extramedullary hematopoiesis. Marked hyperbilirubinemia as a presenting sign of PMF progression, however, has not been reported. We present the case of a patient with a remote diagnosis of PMF, who presented with marked hyperbilirubinemia with a notable response to ruxolitinib.
format Online
Article
Text
id pubmed-9167125
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-91671252022-06-05 Marked Hyperbilirubinemia Associated with Primary Myelofibrosis Responsive to Ruxolitinib Sandhu, Sunny Chaudhry, Hunza Zhang, Sharon Prajapati, Devang Case Reports Hepatol Case Report Primary myelofibrosis (PMF) is a chronic myeloproliferative disorder seen in older adults which can present both with hepatosplenomegaly as well as mild nonspecific liver enzyme abnormalities. Mild elevations in bilirubin can occasionally be seen due to both intravascular hemolysis as well as extramedullary hematopoiesis. Marked hyperbilirubinemia as a presenting sign of PMF progression, however, has not been reported. We present the case of a patient with a remote diagnosis of PMF, who presented with marked hyperbilirubinemia with a notable response to ruxolitinib. Hindawi 2022-05-28 /pmc/articles/PMC9167125/ /pubmed/35669160 http://dx.doi.org/10.1155/2022/9630996 Text en Copyright © 2022 Sunny Sandhu et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Sandhu, Sunny
Chaudhry, Hunza
Zhang, Sharon
Prajapati, Devang
Marked Hyperbilirubinemia Associated with Primary Myelofibrosis Responsive to Ruxolitinib
title Marked Hyperbilirubinemia Associated with Primary Myelofibrosis Responsive to Ruxolitinib
title_full Marked Hyperbilirubinemia Associated with Primary Myelofibrosis Responsive to Ruxolitinib
title_fullStr Marked Hyperbilirubinemia Associated with Primary Myelofibrosis Responsive to Ruxolitinib
title_full_unstemmed Marked Hyperbilirubinemia Associated with Primary Myelofibrosis Responsive to Ruxolitinib
title_short Marked Hyperbilirubinemia Associated with Primary Myelofibrosis Responsive to Ruxolitinib
title_sort marked hyperbilirubinemia associated with primary myelofibrosis responsive to ruxolitinib
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167125/
https://www.ncbi.nlm.nih.gov/pubmed/35669160
http://dx.doi.org/10.1155/2022/9630996
work_keys_str_mv AT sandhusunny markedhyperbilirubinemiaassociatedwithprimarymyelofibrosisresponsivetoruxolitinib
AT chaudhryhunza markedhyperbilirubinemiaassociatedwithprimarymyelofibrosisresponsivetoruxolitinib
AT zhangsharon markedhyperbilirubinemiaassociatedwithprimarymyelofibrosisresponsivetoruxolitinib
AT prajapatidevang markedhyperbilirubinemiaassociatedwithprimarymyelofibrosisresponsivetoruxolitinib